机构:[1]Chongqing Gen Hosp, Dept Otolaryngol Head & Neck Surg, Chongqing 401147, Peoples R China[2]Shanxi Univ Chinese Med, Lab Integrated Med Tumor Immunol, Taiyuan 030000, Peoples R China[3]Hebei Med Univ, Hosp 4, Dept Otolaryngol Head & Neck Surg, 12 Jiankang Rd, Shijiazhuang 050000, Hebei, Peoples R China临床科室耳鼻喉科河北医科大学第四医院[4]Hebei Univ Chinese Med, Dept Pathobiol & Immunol, Shijiazhuang 050200, Peoples R China[5]Chongqing Gen Hosp, Dept Otolaryngol Head & Neck Surg, 118 Xingguang Ave, Liangjiang New Area, Chongqing 401147, Peoples R China
BackgroundLymph nodes metastasis is the main metastasis mode of tongue squamous cell carcinoma (TSCC). Ras related GTP binding protein B (RalB) have been recently described that it was involved in tumor growth and metastasis, but the effect in TSCC is still ill-defined.ObjectiveThis study provides insights into the role of RALB as a prognostic factor in head and neck squamous cell carcinoma (HNSCC) and demonstrates its involvement in promoting lymph node metastasis in TSCC.MethodsFirstly, the expression level of RALB and the relationship with clinical features were examined. Subsequently, RALB knockdown Cal-27 cells orthotopic xenotransplantation in the tongue of BALB/c nude mice were established. Finally, using Connectivity Map (CMAP) database to find possible drugs.ResultsFirstly, RALB could not only predict the cancer patients' prognosis and survival and but also act as a potential prognostic factor, particularly in HNSCC by pan-cancer bioinformatics analysis. In addition, we found that RalB promoted tumor growth and lymph node metastasis. Finally, we identified Tirabrutinib (ONO-4059) targeting RalB with good binding properties.ConclusionsRalB act as a prognostic gene in HNSCC, and promote lymph node metastasis in early stage of TSCC.
基金:
Science and Health Joint Project of Chongqing; Medical research topic of Hebei Province Health Commission [20230135]; [2020ZY013586]
第一作者机构:[1]Chongqing Gen Hosp, Dept Otolaryngol Head & Neck Surg, Chongqing 401147, Peoples R China[4]Hebei Univ Chinese Med, Dept Pathobiol & Immunol, Shijiazhuang 050200, Peoples R China
通讯作者:
通讯机构:[1]Chongqing Gen Hosp, Dept Otolaryngol Head & Neck Surg, Chongqing 401147, Peoples R China[2]Shanxi Univ Chinese Med, Lab Integrated Med Tumor Immunol, Taiyuan 030000, Peoples R China[5]Chongqing Gen Hosp, Dept Otolaryngol Head & Neck Surg, 118 Xingguang Ave, Liangjiang New Area, Chongqing 401147, Peoples R China